Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$976.96 3.16 (0.32%) as of 4:30 Mon 5/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 102.28(B)
Last Volume: 284,348 Avg Vol: 769,142
52 Week Range: $692.45 - $993.35
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 24,729 84,192 120,701 282,978
Total Sell Value $23,631,267 $76,701,012 $107,160,703 $220,505,683
Total People Sold 7 13 15 17
Total Sell Transactions 14 38 55 116
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1366
  Page 15 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Landry Robert E EVP Finance CFO   •       –      –    2022-04-01 4 AS $695.50 $219,875 D/D (316) 28,744 -10%     
   Schleifer Leonard S President & CEO   •       •      –    2022-03-31 4 AS $710.01 $2,049,089 I/I (2,886) 18,292 -8%     
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-31 4 D $700.99 $829,972 D/D (1,184) 29,060     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-31 4 OE $399.66 $599,490 D/D 1,500 30,244     -
   Fenimore Christopher R. SVP Controller   •       –      –    2022-03-31 4 D $700.99 $6,066,367 D/D (8,654) 24,771     -
   Fenimore Christopher R. SVP Controller   •       –      –    2022-03-31 4 OE $270.43 $3,815,640 D/D 12,000 31,628     -
   Bassler Bonnie L Director   –       •      –    2022-03-30 4 AS $700.00 $868,000 D/D (1,240) 1,082 -10%     
   Bassler Bonnie L Director   –       •      –    2022-03-30 4 OE $380.95 $472,378 D/D 1,240 2,322     -
   Goldstein Joseph L Director   –       •      –    2022-03-30 4 AS $700.00 $1,701,700 D/D (2,431) 6,082 -10%     
   Goldstein Joseph L Director   –       •      –    2022-03-30 4 OE $374.12 $909,486 D/D 2,431 8,513     -
   Vagelos P Roy Director   –       •      –    2022-03-30 4 AS $700.00 $20,000,686 I/I (28,572) 23,461 -10%     
   Brown Michael S Director   –       •      –    2022-03-30 4 AS $699.00 $285,192 D/D (408) 1,082 -10%     
   Brown Michael S Director   –       •      –    2022-03-30 4 OE $374.12 $152,641 D/D 408 1,490     -
   Brown Michael S Director   –       •      –    2022-03-29 4 AS $699.00 $1,063,878 D/D (1,522) 1,082 -10%     
   Brown Michael S Director   –       •      –    2022-03-29 4 OE $374.12 $569,411 D/D 1,522 2,604     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-29 4 AS $681.90 $1,845,630 D/D (2,683) 28,744 -10%     
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-28 4 D $685.26 $8,097,717 D/D (11,817) 31,427     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-28 4 OE $399.66 $6,185,095 D/D 14,500 34,212     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-21 4 D $691.31 $215,689 D/D (312) 28,744     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-21 4 OE $381.92 $152,768 D/D 400 29,056     -
   Landry Robert E EVP Finance CFO   •       –      –    2022-03-21 4 AS $693.00 $207,900 D/D (300) 28,656 -16%     
   Tessier-Lavigne Marc Director   –       •      –    2022-03-21 4 AS $690.00 $5,132,910 D/D (7,439) 2,269 -16%     
   Tessier-Lavigne Marc Director   –       •      –    2022-03-21 4 OE $380.95 $2,833,887 D/D 7,439 9,708     -
   Tessier-Lavigne Marc Director   –       •      –    2022-03-17 4 AS $680.00 $5,324,400 D/D (7,830) 2,269 -14%     
   Tessier-Lavigne Marc Director   –       •      –    2022-03-17 4 OE $376.69 $2,949,483 D/D 7,830 10,099     -
  1366 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us